Chemiluminescent reagent and assay using a substituted acetanilide for light generation

• US 5,705,357 A
• Filed: 08/29/1994
• Issued: 01/06/1998
• Est. Priority Date: 08/29/1994
• Status: Expired due to Term

• Current Assignee: Clinical Diagnostic Systems Inc.
• Original Assignee: Johnson & Johnson Clinical Diagnostics Inc. (Johnson & Johnson)
• Inventors: Friedman, Alan E., Fingar, Sarah A., Kissel, Thomas Robert
• Primary Examiner(s): Houtteman, Scott W.
• Application Number:
  US08/297,475
• Time in Patent Office: 1,226 Days
• Field of Search: 435/6, 435/7.1, 435/7.2, 435/7.21, 435/7.22, 435/7.23, 435/7.24, 435/7.25, 435/28, 436/172, 436/543, 436/826
• US Class Current: 435/28
• CPC Class Codes: C12Q 1/28 involving peroxidase
• CPC Class Codes: G01N 33/535 with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
• CPC Class Codes: G01N 33/582 with fluorescent label

Abstract

A simplified composition for generating a chemiluminescent signal in the presence of a peroxidase includes a substituted acetanilide as the sole light-producing substrate for the peroxidase. Assays for various analytes can be carried out with this composition at near neutral pH, exhibit low background and are highly sensitive.

Claims

1. An aqueous composition for providing a chemiluminescent signal comprising:

a) an oxidant in an amount of from about 1 to about 10 mmolar,

b) a low molecular weight cationic surfactant present at from about 0.05 to about 2% above its critical micelle concentration, or a cationic polymer present at from about 0.01 to about 2% by weight,

c) a buffer to maintain the pH of said composition at from about 6 to about 8.5, and

d) a substituted acetanilide which is present in a total amount of from about 0.05 to about 10 mmolar as the sole chemiluminescent signal generating reagent which provides a signal in response to the catalytic activity of peroxidase, said substituted acetanilide having the structure (I);

##STR4## wherein R¹ is hydrogen or alkyl of 1 to 4 carbon atoms,

R² is hydrogen, alkyl of 1 to 4 carbon atoms, alkoxyalkyl of 1 to 4 carbon atoms, hydroxyalkyl of 1 to 4 carbon atoms, aminoalkyl of 1 to 4 carbon atoms, haloalkyl of 1 to 4 carbon atoms, or alkenyl of 2 to 5 carbon atoms,

R³ is hydrogen or alkyl of 1 to 4 carbon atoms,

at least one of R⁴ and R⁵ is an electron withdrawing group having a Hammet sigma value of at least about 0.01, wherein any R⁴ or R⁵ which is not said electron withdrawing group is hydrogen, and R⁶ and R⁷ are independently hydrogen, halo, cyano or methyl,

provided that said composition is substantially free of any other chemiluminescent agent.

2. The composition of claim 1 wherein R¹ is hydrogen or methyl, R² is hydrogen, methyl, methoxymethyl, hydroxymethyl, chloromethyl or ethenyl, R³ is hydrogen or methyl, R⁴ and R⁵ are independently hydrogen, halo or cyano, and R⁶ and R⁷ are independently hydrogen, chloro or methyl.

3. The composition of claim 2 wherein R¹ is hydrogen, R² is hydrogen or methyl, R³ is hydrogen, at least one of R⁴ and R⁵ is chloro or bromo, and R⁶ and R⁷ are each hydrogen.

4. The composition of claim 1 further comprising peroxidase or a peroxidase-labeled specific binding molecule.

5. The composition of claim 1 wherein said cationic surfactant is cetyltrimethylammonium bromide or cetyltrimethylammonium chloride.

6. The composition of claim 5 wherein said oxidant is hydrogen peroxide, said buffer is tris(hydroxymethyl)aminomethane, and said substituted acetanilide is 3'"'"'-chloro-4'"'"'-hydroxyacetanilide or 3'"'"'-bromo-4'"'"'-hydroxyacetanilide.

7. The composition of claim 1 wherein said oxidant is present in an amount of from about 1 to about 10 mmolar, said low molecular weight cationic surfactant is present in an amount of from about 0.05 to about 2% above the critical micelle concentration, or said cationic polymer is present in an amount of from about 0.01 to about 2 weight %, and said substituted acetanilide is present in an amount of from about 0.05 to about 10 mmolar.

8. A diagnostic test kit for the determination of an analyte catalytically related to peroxidase, said kit comprising, in individual packaging:

i) the aqueous composition of claim 1, and

ii) a peroxidase or a peroxidase-labeled specific binding species.

9. The test kit of claim 8 wherein said peroxidase-labeled specific binding species is a peroxidase-labeled antibody or a peroxidase-labeled specific binding ligand analogue.

10. A test device for the detection of peroxidase or an analyte catalytically related to peroxidase, said test device comprising an absorbent carrier material and the composition of claim 1.

11. A method for producing a detectable signal in response to peroxidase comprising:

A) reacting a peroxidase in the presence of the composition of claim 1 to produce a detectable chemiluminescent signal, and

B) determining the resulting chemiluminescent signal as a measure of peroxidase.

12. The method of claim 11 wherein said peroxidase is detected as part of a peroxidase-labeled specific binding complex.

13. A specific binding assay for the determination of a specific binding ligand comprising:

A) forming a peroxidase-labeled specific binding complex of a specific binding ligand with a receptor specific for said ligand,

B) after separating uncomplexed materials from said peroxidase-labeled specific binding complex, contacting said peroxidase-labeled complex with the composition of claim 1 to produce a detectable chemiluminescent signal, and

C) determining the resulting chemiluminescent signal as a measure of said specific binding ligand.

14. The method of claim 13 wherein said specific binding ligand is complexed with a first and second receptor therefor, said first receptor being a capture reagent, and said second receptor being a detection reagent which binds with peroxidase or is a peroxidase-labeled reagent, thereby forming a sandwich of said ligand and said first and second receptors.

15. The method of claim 14 for the determination of an antigen as said specific binding species, and wherein said first and second receptors are antibodies specific to said antigen.

16. The method of claim 13 wherein said specific binding ligand competes with a peroxidase-labeled specific binding ligand for a single receptor specific for said specific binding ligand.

17. The method of claim 14 for the determination of a nucleic acid wherein said first and second receptors are oligonucleotides which are complementary to different sequences of said nucleic acid.